Literature DB >> 2887184

Successful use of a right ventricular assist device.

P Belcher, B Glenville, L Cooper.   

Abstract

Right ventricular failure caused by myocardial infarction may be refractory to treatment designed to support the systemic ventricle. A new type of right ventricular assist device driven by an impeller pump was successfully used for 79 hours after emergency revascularisation after right coronary occlusion. Despite renal failure requiring haemofiltration the patient has now fully recovered.

Entities:  

Mesh：

Year:  1987        PMID： 2887184      PMCID： PMC1277296          DOI： 10.1136/hrt.58.2.162

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  6 in total

1.  Right ventricular infarction. Clinical and hemodynamic features.

Authors:  J N Cohn; N H Guiha; M I Broder; C J Limas
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

2.  Intrapulmonary artery balloon pumping. Assistance of the right ventricle.

Authors:  A C Kralios; H H Zwart; S D Moulopoulos; R Collan; C S Kwan-Gett; W J Kolff
Journal:  J Thorac Cardiovasc Surg       Date:  1970-08       Impact factor: 5.209

3.  Right ventricular function during left heart bypass.

Authors:  A T Miyamoto; S Tanaka; J M Matloff
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

4.  Pulmonary artery balloon counterpulsation for acute right ventricular failure.

Authors:  D C Miller; R J Moreno-Cabral; E B Stinson; J A Shinn; N E Shumway
Journal:  J Thorac Cardiovasc Surg       Date:  1980-11       Impact factor: 5.209

5.  Pulmonary circulatory support. A quantitative comparison of four methods.

Authors:  W E Gaines; W S Pierce; G A Prophet; K Holtzman
Journal:  J Thorac Cardiovasc Surg       Date:  1984-12       Impact factor: 5.209

6.  Pulmonary artery balloon counterpulsation for right ventricular failure. An experimental evaluation.

Authors:  G K Jett; L G Siwek; A L Picone; R E Applebaum; M Jones
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.